|
Designated Public Office Holders who participated in the communication:
|
Supriya Sharma,
Chief Medical Officer
Health Canada (HC)
|
| |
List of Details
|
Subject matter
|
Detail
|
|
Health
|
Health Canada as it pertains to the approval of disease-modifying treatments for Alzheimer's disease and other dementias that aim to slow or halt the progression of the disease.
|
|
| |
|
Responsible Officer who filed this communication report:
|
Sarah Calderwood
|
| |
|
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
|
| |
